<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001193805-24-001310</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Safier Jacob -->
          <cik>0001381740</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001492674</issuerCik>
        <issuerName>T2 Biosystems, Inc.</issuerName>
        <issuerCusip>89853L302</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>101 HARTWELL AVENUE</com:street1>
          <com:city>LEXINGTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02421</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Safier Jacob</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1500000.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1500000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1500000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.3</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>JSAF Holdings, LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1500000.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1500000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1500000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.3</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>T2 Biosystems, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>101 Hartwell Ave., Lexington, MA 02421</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>JSAF Holdings, LLC ("JSAF")

Jacob Safier

Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>JSAF Holdings, LLC
c/o The Wolfson Group
One State Street Plaza, 29th Floor
New York, NY 10004

Jacob Safier
c/o The Wolfson Group
One State Street Plaza, 29th Floor
New York, NY 10004</principalBusinessOfficeOrResidenceAddress>
        <citizenship>JSAF Holdings, LLC
Delaware

Jacob Safier
United States</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>As of the date hereof:

JSAF beneficially owns 1,500,000 Shares.

Jacob Safier, as the manager of the T2 Biosystems, Inc. investment by JSAF, may be deemed to beneficially own the Shares owned by JSAF and, therefore, may be deemed to beneficially own 1,500,000 Shares. Mr. Safier disclaims beneficial ownership of the Shares owned by JSAF.</amountBeneficiallyOwned>
        <classPercent>As of the date hereof, JSAF beneficially owned and Jacob Safier may be deemed to beneficially own 5.3% (based upon 28,045,417 Shares outstanding, which is the number of Shares reported as outstanding in the Issuer's Proxy Statement on Schedule 14-A filed with the Securities and Exchange Commission on January 21, 2025).</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>1,500,000 Shares.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0 Shares.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>1,500,000 Shares.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0 Shares.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Safier Jacob</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Jacob Safier</signature>
        <title>Jacob Safier</title>
        <date>02/13/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>JSAF Holdings, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Jacob Safier</signature>
        <title>Jacob Safier, Manager</title>
        <date>02/13/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
